Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

AVI BioPharma, Inc. , a developer of RNA-based drugs, announced the appointment of Stephen B. Shrewsbury, M.D., as Chief Medical Officer and Senior Vice President of Clinical and Regulatory Affairs.

 

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address